Literature DB >> 368433

Immunohistologic demonstration of hepatitis B viral antigens in liver with reference to its significance in liver injury.

S N Huang, A R Neurath.   

Abstract

Indirect immunoperoxidase stainings for hepatitis B core and surface antigens (HBc&s Ag) were applied to formalin-fixed paraffin sections in 113 liver specimens from 56 patients. Many cytomorphologic staining characteristics of HBc&s Ag were illustrated, and the percentages of the cellular population positive for HBc&s Ag were estimated for all specimens in order to provide the basis for general analyses. The quantitative expressions and the topographic distribution of HBc&s Ag were assessed with respect to their significance and implication in histopathologic reactions. A definitive relationship or relevance was neither established nor completely excluded due to the size of samples. However, cytomorphologically the membranous expression of HBc&s Ag was shown often in association with acute lobular hepatitis and chronic active hepatitis. This observation supports the concept that the membranous expression may be the prerequisite for immune mediated hepatitic injury in viral hepatitis. In this study we also carried out indirect immunoferritin and immunoperoxidase electron microscopy for HBc&s Ag on formalin-fixed liver specimens. The results assured the validity of the light microscopic immunohistologic procedures. The immunoelectron microscopy confirmed the presence of core antigen in the Dane particles formation that takes place in the cisternae of endoplasmic reticulum. The significance of the cytoplasmic core antigen and the possible role of immunoelectron microscopy in the elucidation of mechanisms of hepatitic injury were discussed.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 368433

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  23 in total

1.  Hepatocyte expression of HBcAg and serum HBeAg in hepatitis B: comparison of polyclonal and monoclonal antibodies during a trial of interferon.

Authors:  C M Chu; S M Lin; Y F Liaw
Journal:  J Clin Pathol       Date:  1991-01       Impact factor: 3.411

Review 2.  Rapid viral diagnosis in perspective.

Authors:  P C Lee; P Hallsworth
Journal:  BMJ       Date:  1990-06-02

3.  Influence of accompanying chronic hepatitis status on recurrence of hepatocellular carcinoma after hepatectomy.

Authors:  P S Russell
Journal:  Ann Surg       Date:  1996-11       Impact factor: 12.969

4.  Pathological study of chronic lobular hepatitis--with special reference to pathology, diagnostic criteria, etiology and pathogenesis on the basis of analysis of 25 liver biopsies.

Authors:  X G Wu; S C Liu; X J Zhang; Z Y Hu
Journal:  J Tongji Med Univ       Date:  1986

5.  Clinicopathological study of fulminant hepatitis: coinfection with hepatitis B virus and delta agent.

Authors:  S Krajden; F Bishai; S N Huang; A Ronald; F Harris; J Kempston; J Anderson; S Keston
Journal:  CMAJ       Date:  1986-12-01       Impact factor: 8.262

Review 6.  Antigens of the human liver.

Authors:  I G McFarlane; B M Wojcicka; R Williams
Journal:  Clin Exp Immunol       Date:  1980-04       Impact factor: 4.330

7.  Preliminary research on the relationship between expression of HBV antigens and liver cell necrosis in the liver tissue of patients with chronic liver diseases.

Authors:  K Q Hu; P H Song; L J Hao
Journal:  J Tongji Med Univ       Date:  1988

8.  Core antigen and antibody in woodchucks after infection with woodchuck hepatitis virus.

Authors:  A Ponzetto; P J Cote; E C Ford; R H Purcell; J L Gerin
Journal:  J Virol       Date:  1984-10       Impact factor: 5.103

9.  Patterns of chronic liver disease in Kuwait with special reference to localisation of hepatitis B surface antigen.

Authors:  M S Al Adnani; S M Ali
Journal:  J Clin Pathol       Date:  1984-05       Impact factor: 3.411

10.  Recurrent hepatitis B in liver allograft recipients. Differentiation between viral hepatitis B and rejection.

Authors:  A J Demetris; R Jaffe; D G Sheahan; J Burnham; J Spero; S Iwatsuki; D H Van Theil; T E Starzl
Journal:  Am J Pathol       Date:  1986-10       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.